Literature DB >> 11473740

Insights into the mechanism of vascular calcification.

K Boström1.   

Abstract

Vascular calcification is common and clinically significant in atherosclerosis and heart failure. It was long believed to be an end-stage process of "passive" mineral precipitation. However, there is now a growing awareness that vascular calcification is a biologically regulated phenomenon. It has many similarities to bone formation, and ectopic bone is a well-documented part of vascular calcification. This implies that alterations in vascular cell differentiation, extensive or localized, are an integral part of vascular calcification. Matrix gamma-carboxylated glutamate (GLA) protein (MGP)-deficient mice develop extensive vascular calcification with replacement of the media by progressively calcifying cartilage. A potential mechanism that explains these findings is MGP interference with bone morphogenetic proteins-potent inducers of cartilage and bone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473740     DOI: 10.1016/s0002-9149(01)01718-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  Pathogenesis of nephrolithiasis: recent insight from cell biology and renal pathology.

Authors:  Giovanni Gambaro; Antonia Fabris; Cataldo Abaterusso; Alex Cosaro; Monica Ceol; Federica Mezzabotta; Rossella Torregrossa; Emilia Tiralongo; Dorella Del Prete; Angela D'Angelo; Franca Anglani
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

2.  Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses.

Authors:  Jeoung Soo Lee; Dina M Basalyga; Agneta Simionescu; Jason C Isenburg; Dan T Simionescu; Narendra R Vyavahare
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Relationship between bone mineral density and myocardial infarction in US adults.

Authors:  Jeanette H Magnus; Danielle L Broussard
Journal:  Osteoporos Int       Date:  2005-10-26       Impact factor: 4.507

4.  Vasomotor symptoms and coronary artery calcium in postmenopausal women.

Authors:  Matthew A Allison; Joann E Manson; Aaron Aragaki; Robert D Langer; Jacques Rossouw; David Curb; Lisa W Martin; Lawrence Phillips; Marcia L Stefanick; Barbara B Cochrane; Gloria Sarto; Janice Barnhart; Mary Jo O'Sullivan; Karen C Johnson; Margery Gass; Maurizio Trevisan; Nancy F Woods
Journal:  Menopause       Date:  2010 Nov-Dec       Impact factor: 2.953

5.  Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea.

Authors:  Lian-Hua Cui; Min-Ho Shin; Eun-Kyung Chung; Young-Hoon Lee; Sun-Seog Kweon; Kyeong-Soo Park; Jin-Su Choi
Journal:  Osteoporos Int       Date:  2005-09-16       Impact factor: 4.507

Review 6.  The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.

Authors:  Katherine Wesseling-Perry; Harald Jüppner
Journal:  Bone       Date:  2012-10-16       Impact factor: 4.398

7.  Valvular calcification and risk of peripheral artery disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Parveen K Garg; Petra Buzkova; Zahra Meyghani; Matthew J Budoff; Joao Lima; Michael Criqui; Mary Cushman; Matthew Allison
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-10-01       Impact factor: 6.875

8.  Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes.

Authors:  Makoto Hirao; Jun Hashimoto; Naomi Yamasaki; Wataru Ando; Hideki Tsuboi; Akira Myoui; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

9.  Reduced bone mineral density is associated with breast arterial calcification.

Authors:  Jhansi Reddy; John P Bilezikian; Suzanne J Smith; Lori Mosca
Journal:  J Clin Endocrinol Metab       Date:  2007-10-30       Impact factor: 5.958

Review 10.  Chronic kidney disease: mineral and bone disorder in children.

Authors:  Katherine Wesseling-Perry; Isidro B Salusky
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.